HCW Biologics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVANTAX PLANNING PARTNERS, INC. | 11/14/2024 | 279,541 | $150,784 | 0.00% | 0.74% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 183,259 | $98,874 | 7.56% | 0.48% |
| HIGHTOWER ADVISORS, LLC | 11/14/2024 | 180,810 | $98,000 | 0.00% | 0.48% |
| CRESSET ASSET MANAGEMENT, LLC | 11/14/2024 | 131,990 | $71,195 | 0.00% | 0.35% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 84,700 | $45,687 | 0.00% | 0.22% |
| PULLEN INVESTMENT MANAGEMENT, LLC | 10/24/2024 | 75,116 | $40,518 | -11.75% | 0.20% |
| HRT FINANCIAL LP | 11/12/2024 | 46,497 | $25,000 | -30.25% | 0.12% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 44,348 | $23,921 | 100.00% | 0.12% |
| VANGUARD GROUP INC | 11/13/2024 | 37,677 | $20,308 | 0.00% | 0.10% |
| AE WEALTH MANAGEMENT LLC | 11/14/2024 | 30,000 | $16,182 | 0.00% | 0.08% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 22,443 | $12,106 | -0.16% | 0.06% |
| STATE STREET CORP | 11/14/2024 | 21,446 | $11,568 | 0.00% | 0.06% |
| NORTHERN TRUST CORP | 11/13/2024 | 10,205 | $5,505 | 0.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 5,881 | $3,172 | -5.33% | 0.02% |
| UBS GROUP AG | 11/14/2024 | 4,831 | $2,604 | 12.74% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 339 | $183 | 117.31% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/15/2024 | 0 | $0 | -100.00% | 0.00% |
HCW Biologics Inc.institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of HCW Biologics Inc.. The most heavily invested institutionals were:
Avantax Planning Partners, Inc.: 279,541
GEODE CAPITAL MANAGEMENT, LLC: 183,259
HighTower Advisors, LLC: 180,810
Cresset Asset Management, LLC: 131,990
BRIDGEWAY CAPITAL MANAGEMENT, LLC: 84,700
Pullen Investment Management, LLC: 75,116
3.06% of HCW Biologics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.20 M shares in the last 24 months. This purchase volume represents approximately $420,611 in transactions.